- Home
- AVNS
AVNS
Avanos Medical Inc.
as 07-26-2024 4:00pm EST
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | ALPHARETTA |
| Market Cap: | 1.0B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 214.2K |
| Analyst Decision: | Hold | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.24 - $24.66 | Next Earning Date: | 08-07-2024 |
| Revenue: | $680,100,000 | Revenue Growth: | -0.58% |
| Revenue Growth (this year): | 5.35% | Revenue Growth (next year): | 4.93% |
Stock Insider Trading Activity of Avanos Medical Inc. (AVNS)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Greiner Michael | AVNS | SVP - Chief Financial Officer | Mar 14 '24 | Sell | $19.11 | 3,800 | $72,618.00 | 155,695 | SEC Form 4 |
| Greiner Michael | AVNS | SVP - Chief Financial Officer | Mar 14 '24 | Sell | $19.12 | 714 | $13,651.68 | 154,981 | SEC Form 4 |
| Greiner Michael | AVNS | SVP - Chief Financial Officer | Mar 14 '24 | Sell | $19.13 | 2,231 | $42,679.03 | 152,750 | SEC Form 4 |
| Greiner Michael | AVNS | SVP - Chief Financial Officer | Mar 14 '24 | Sell | $19.14 | 337 | $6,450.18 | 152,413 | SEC Form 4 |
| Greiner Michael | AVNS | SVP - Chief Financial Officer | Mar 14 '24 | Sell | $19.15 | 808 | $15,473.20 | 151,605 | SEC Form 4 |
| Greiner Michael | AVNS | SVP - Chief Financial Officer | Mar 14 '24 | Sell | $19.16 | 110 | $2,107.60 | 151,495 | SEC Form 4 |
| Shimer Julie Ann | AVNS | Director | Mar 11 '24 | Buy | $19.85 | 500 | $9,925.00 | 50,090 | SEC Form 4 |
Latest Avanos Medical Inc. News
AVNS Breaking Stock News: Dive into AVNS Ticker-Specific Updates for Smart Investing
Zacks
8 hours ago
Three Reasons to Retain Avanos (AVNS) Stock in Your Portfolio
Simply Wall St.
a day ago
Avanos Medical (NYSE:AVNS) investors are sitting on a loss of 44% if they invested five years ago
PR Newswire
2 days ago
Avanos Medical, Inc. to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
PR Newswire
a month ago
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
CNW Group
2 months ago
Lotto 6/49 - $64 million up for grabs in the next draw!
Simply Wall St.
2 months ago
Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
AFP
2 months ago
Seoul says it will resume loudspeaker propaganda against North
Simply Wall St.
2 months ago
It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
Compare AVNS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AVNS Avanos Medical Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.